Skip to main content
Insights into Imaging

Table 4 Comparison of the 3-year DFS rate of different treatment modalities in NT group and between NT group and CCRT group

From: MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results

Index

Number

3-year DFS rate (%)

p value

Neoadjuvant treatment

  

0.967

  NAC

31

84.0

 

  NAR

28

82.0

 

  NACR

27

78.0

 

Adjuvant treatment

  

0.217

  Adjuvant treatment

38

73.0

 

  Nonadjuvant treatment

48

88.0

 

Adjuvant treatment

  

0.061

  ACT

7

100.0

 

  ART

6

100.0

 

  ACRT

25

60.0

 

Treatment

  

0.863

  NT + RH

86

81.0

 

  CCRT

63

80.0

 
  1. NAC neoadjuvant chemotherapy; NAR neoadjuvant radiotherapy; NACR neoadjuvant chemoradiotherapy; ACT adjuvant chemotherapy; ART adjuvant radiotherapy; ACRT adjuvant chemoradiotherapy; NAT + RH neoadjuvant therapy followed by radical hysterectomy; CCRT concurrent chemoradiation
Back to article page